Literature DB >> 6729217

Effect of adjuvant therapy in primary breast cancer in relation to the estrogen receptor level.

A Wallgren, U Glas, S Gustafsson, L Skoog, N O Theve, B Nordenskjöld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6729217     DOI： 10.1007/978-3-642-82188-2_30

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  3 in total

1.  Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

Authors:  A J Wilson; M Baum; D M Brinkley; J A Dossett; K McPherson; J S Patterson; R D Rubens; F G Smiddy; B A Stoll; D Richards
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

2.  The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.

Authors:  L E Rutqvist; B Cedermark; U Glas; H Johansson; B Nordenskjöld; L Skoog; A Somell; T Theve; S Friberg; J Askergren
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

3.  Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centre.

Authors:  L Mauriac; M Durand; J Chauvergne; F Bonichon; A Avril; P Mage; M H Dilhuydy; A Le Treut; J Wafflart; D Marée
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.